ProMIS Neurosciences, Inc.
PMN
$0.5359
-$0.0131-2.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 196.52% | 115.16% | 34.95% | -29.10% | -54.00% |
| Gross Profit | -196.52% | -115.16% | -34.95% | 29.10% | 54.00% |
| SG&A Expenses | -38.59% | -51.60% | -57.84% | -10.29% | -18.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 92.31% | 31.94% | -6.56% | -22.27% | -43.06% |
| Operating Income | -92.31% | -31.94% | 6.56% | 22.27% | 43.06% |
| Income Before Tax | 30.92% | 92.14% | 121.03% | 96.67% | 40.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.92% | 92.14% | 121.03% | 96.67% | 40.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.92% | 92.14% | 121.03% | 96.67% | 40.47% |
| EBIT | -92.31% | -31.94% | 6.56% | 22.27% | 43.06% |
| EBITDA | 45.69% | 25.56% | 6.57% | 22.43% | 43.17% |
| EPS Basic | 71.27% | 95.02% | 98.64% | 89.87% | 72.72% |
| Normalized Basic EPS | 85.77% | 107.12% | 106.86% | 89.87% | 72.71% |
| EPS Diluted | 71.27% | 95.02% | 98.64% | 89.87% | 72.72% |
| Normalized Diluted EPS | 85.70% | 107.06% | 106.83% | 89.84% | 72.71% |
| Average Basic Shares Outstanding | 88.80% | 98.88% | 112.05% | 134.27% | 117.41% |
| Average Diluted Shares Outstanding | 88.87% | 98.95% | 112.14% | 134.39% | 117.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |